ProQR Therapeutics N.V annual revenue
2021
2022
2023
2024
2025
ProQR Therapeutics N.V Revenue Growth & History (PRQR)
ProQR Therapeutics N.V reported €15.9M in revenue for fiscal 2025, a decrease of 15.86% from the previous fiscal year.
View full ProQR Therapeutics N.V company overviewProQR Therapeutics N.V annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €15.9M | −€3.0M | −15.86% |
| 2024 | 2024-12-31 | €18.9M | €12.4M | +190.22% |
| 2023 | 2023-12-31 | €6.5M | €2.9M | +81.25% |
| 2022 | 2022-12-31 | €3.6M | €2.3M | +169.21% |
| 2021 | 2021-12-31 | €1.3M | — | — |
ProQR Therapeutics N.V quarterly revenue
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €8.8M | €4.9M | +129.47% |
| Q1 2026 | 2026-03-31 | €2.0M | −€2.5M | −55.01% |
| Q4 2025 | 2025-12-31 | €4.7M | €381,000 | +8.85% |
| Q3 2025 | 2025-09-30 | €2.9M | −€961,000 | −25.01% |
| Q2 2025 | 2025-06-30 | €3.8M | −€2.5M | −39.46% |
| Q1 2025 | 2025-03-31 | €4.5M | €69,000 | +1.55% |
| Q4 2024 | 2024-12-31 | €4.3M | €1.0M | +31.15% |
| Q3 2024 | 2024-09-30 | €3.8M | €2.5M | +180.51% |
| Q2 2024 | 2024-06-30 | €6.3M | €5.1M | +423.24% |
| Q1 2024 | 2024-03-31 | €4.5M | €3.8M | +579.39% |
| Q4 2023 | 2023-12-31 | €3.3M | €2.6M | +356.11% |
| Q3 2023 | 2023-09-30 | €1.4M | €556,000 | +68.30% |
| Q2 2023 | 2023-06-30 | €1.2M | €275,000 | +29.57% |
| Q1 2023 | 2023-03-31 | €655,000 | −€475,000 | −42.04% |
| Q4 2022 | 2022-12-31 | €720,000 | — | — |
| Q3 2022 | 2022-09-30 | €814,000 | −€58,000 | −6.65% |
| Q2 2022 | 2022-06-30 | €930,000 | €687,000 | +282.72% |
| Q1 2022 | 2022-03-31 | €1.1M | — | — |
| Q3 2021 | 2021-09-30 | €872,000 | — | — |
| Q2 2021 | 2021-06-30 | €243,000 | — | — |
ProQR Therapeutics N.V revenue growth trends
ProQR Therapeutics N.V's latest reported quarter, Q2 2026, generated €8.8M in revenue, an increase of 129.47% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review ProQR Therapeutics N.V source filings ↗